Skip to main content

Table 1 Comparison of basic data between the case group and the control group

From: Correlation of catecholamine content and clinical influencing factors in depression among psoriasis patients: a case-control study

 

The Psoriasis group

The Control group

zχ2

P

Number, n

90

40

  

Age (year)

44(25-53)

44(31-50)

-0.374

0.709

Sex (male), n(%)

67(74)

26(65)

1.213

0.271

Course of disease (month)

78(12-120)

   

Poor economic condition, n (%)

21(23)

4(10)

2.369

0.124

HAMD score

3(0-9)

2(0-4)

-2.115

0.034

PASI score

31(21-39)

   

DLQI score

5(2-9)

   

AIS score

2(0-9)

0(0-1)

-3.407

0.001

Phenylephrine (pg/ml)

30.84(29.16-33.29)

36.77(29.79-41.18)

-2.679

0.007

Norepinephrine (pg/ml)

149.28(141.78-161.13)

154.52(142.51-163.88)

-1.407

0.159

Dopamine (pg/ml)

53.73.(49.73-56.67)

57.08(52.78-63.11)

-2.916

0.004

  1. HAMD Hamilton Depression Scale, PASI Psoriasis Area and Severity Index, DLQI Dermatology Life Quality Index, AIS Athens Insomnia Scale